Category: Clinical trials

GSK Announces NEJM Publication of Phase 3b/4 Study of Ambrisentan and Tadalafil as First-Line Combination Treatment in Patients with Pulmonary Arterial Hypertension

London, UK -- 26 August 2015 -- GSK today announced publication of the AMBITION study, the first outcomes study to compare the safety and efficacy of investigational first-line combination therapy of Volibris® (ambrisentan) and Adcirca®...

Pivotal Phase II Study of Investigational Medicine Venetoclax Met Primary Endpoint in a Hard-To-Treat Type of Chronic Lymphocytic Leukemia

South San Francisco, CA -- August 12, 2015 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced positive results today from the Phase II M13-982 study of venetoclax, an investigational medicine being developed in...